Mammograms and Younger Women: The New Findings
False-positives are a potential downside of breast cancer screening, and one that the US Preventive Services Task Force (USPSTF) says patients and their doctors should consider.
The Latest Word on Breast Cancer Screening
The US Preventive Services Task Force (USPSTF) has now issued its final recommendations on breast cancer screening, including a discussion of the potential benefits and harms of mammography performed every two years.
Rethinking Breast Cancer Screening
Doctors may now have a new — and equally effective — breast cancer screening tool in their arsenal.
New Hope for Fertility After Cancer
Young women with invasive breast cancer are often faced with a difficult choice: whether or not to undergo chemotherapy despite its risk of infertility.
Breast Cancer Rxs Go Head to Head
The current front-line treatment for early breast cancer, tamoxifen, may have met its match.
Protecting the Heart During Chemo
Chemotherapy can greatly improve cancer patients' chances of survival. But with this treatment comes a serious and equally life-threatening risk: heart failure.
When Chemo Fails, This Rx May Help
Breast cancer patients and their doctors may now have a new tool in their toolbox.
Bone Rx Boosted Breast Cancer Survival
Nearly all postmenopausal women with early-stage HR+ breast cancer are treated with aromatase inhibitors. But these drugs can significantly compromise bone health and up the risk of fractures.
Approved: Possible Solution to Chemotherapy Hair Loss
Women facing chemotherapy for breast cancer may face another side effect: hair loss. But a new device could fight back.
Tamoxifen and Antidepressants: The New Findings
Breast cancer survivors are often prescribed antidepressants to ward off hot flashes and other side effects of the cancer drug tamoxifen. But some experts worry that this practice may make tamoxifen less effective.